Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | ABHD6 | Q9BV23 | 9/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | GALR3 | O60755 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 2/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL385055 | 0.82 | TSHR (0.36) | TSHRTDP1ALDH1A1CA1CA2 | |
| SCHEMBL21208171 | 0.79 | ABHD6 (0.35) | TSHRABHD6CA1CA2CA9 | |
| SCHEMBL27937250 | 0.78 | TSHR (0.46) | TSHRTDP1CHRM2CHRM4CHRM1 | |
| SCHEMBL20570031 | 0.77 | TSHR (0.40) | TSHRTDP1CHRM2CHRM4CHRM1 | |
| SCHEMBL10239353 | 0.77 | TSHR (0.32) | TSHR | |
| SCHEMBL15824292 | 0.77 | CA1 (0.36) | ABHD6CA1CA2CA9MGLL | |
| SCHEMBL719545 | 0.77 | CA1 (0.36) | ABHD6CA1CA2CA9MGLL | |
| SCHEMBL14814855 | 0.77 | ABHD6 (0.35) | ABHD6CA1CA2CA9 | |
| SCHEMBL26548459 | 0.76 | TSHR (0.31) | TSHR | |
| SCHEMBL17958378 | 0.76 | ABHD6 (0.40) | ABHD6ALDH1A1CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240194955-A1 | ELECTROLYTES OF RECHARGEABLE LITHIUM-SULFUR BATTERIES AND LITHIUM-SULFUR BATTERIES INCLUDING THE SAME | GINER INC (US) | 2024-06-13 | — | — | US | claimed |
| US-11814348-B2 | Oxidizing liquid media for chemical transformations | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2023-11-14 | — | — | US | claimed |
| WO-2022221636-A2 | ELECTROLYTES OF RECHARGEABLE LITHIUM-SULFUR BATTERIES AND LITHIUM-SULFUR BATTERIES INCLUDING THE SAME | GINER, INC. (US) | 2022-10-20 | — | — | WO | claimed |
| US-9427777-B2 | Process for producing charge retention medium | ASAHI GLASS COMPANY, LIMITED (JP) | 2016-08-30 | — | — | US | claimed |
| US-12534657-B2 | Two-phase immersion cooling | NANO AND ADVANCED MATERIALS INSTITUTE LIMITED (HK) | 2026-01-27 | — | — | US | disclosed |
| WO-2025091685-A1 | FLUORINATED LIQUID COMPOSITION AND USE THEREOF | 深圳市鸿富诚新材料股份有限公司 | 2025-05-08 | — | — | WO | disclosed |
| US-20240194955-A1 | ELECTROLYTES OF RECHARGEABLE LITHIUM-SULFUR BATTERIES AND LITHIUM-SULFUR BATTERIES INCLUDING THE SAME | GINER INC (US) | 2024-06-13 | — | — | US | disclosed |
| US-20240130086-A1 | MULTIMODE IMMERSION COOLING | NANO AND ADVANCED MATERIALS INSTITUTE LIMITED (HK) | 2024-04-18 | — | — | US | disclosed |
| US-20240030494-A1 | LITHIUM SECONDARY BATTERY | TERAWATT TECHNOLOGY K.K. (JP) | 2024-01-25 | — | — | US | disclosed |
| US-20240030494-A1 | LITHIUM SECONDARY BATTERY | TERAWATT TECHNOLOGY K.K. (JP) | 2024-01-25 | — | — | US | disclosed |
| US-11814348-B2 | Oxidizing liquid media for chemical transformations | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2023-11-14 | — | — | US | disclosed |
| US-20230303901-A1 | TWO-PHASE IMMERSION COOLING | NANO AND ADVANCED MATERIALS INSTITUTE LIMITED (HK) | 2023-09-28 | — | — | US | disclosed |
| US-8211984-B2 | Ring-opening metathesis polymer, hydrogenated product thereof, method for preparing the same, and use thereof | MITSUI CHEMICALS, INC. (JP) | 2012-07-03 | — | — | US | disclosed |
| US-7910222-B2 | Polymerizable composition for forming optical device, optical device and method for producing optical device | FUJIFILM CORPORATION (JP) | 2011-03-22 | — | — | US | disclosed |
| US-20100028804-A1 | RESIST COMPOSITION AND METHOD OF FORMING PATTERN THEREWITH | FUJIFILM CORPORATION (JP) | 2010-02-04 | — | — | US | disclosed |
| US-20090215974-A1 | RING-OPENING METATHESIS POLYMER, HYDROGENATED PRODUCT THEREOF, METHOD FOR PREPARING THE SAME, AND USE THEREOF | MITSUI CHEMICALS INC (JP) | 2009-08-27 | — | — | US | disclosed |
| EP-2045280-A1 | RING-OPENING METATHESIS POLYMERS, PRODUCTS OF HYDROGENATION THEREOF, PROCESS FOR PRODUCTION OF THE SAME AND USES THEREOF | Mitsui Chemicals, Inc. (JP) | 2009-04-08 | — | — | EP | disclosed |
| EP-2003509-A2 | Pattern forming method | FUJIFILM Corporation (JP) | 2008-12-17 | — | — | EP | disclosed |
| US-20070299204-A1 | Polymerizable Composition for Forming Optical Device, Optical Device and Method for Producing Optical Device | FUJIFILM CORPORATION (JP) | 2007-12-27 | — | — | US | disclosed |
| CN-1262276-A | Phosphine sulfide preparing process and use thereof | MITSUI CHEMICALS INC (JP) | 2000-08-09 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11814348-B2 | Oxidizing liquid media for chemical transformations | HAO2, LPO, DUOX1 | TSHR 1383/4885ABHD6 1148/4885TDP1 1980/4885 |
| US-12534657-B2 | Two-phase immersion cooling | AFF2, HSF1, AFF1 | TSHR 1695/4885ABHD6 3985/4885TDP1 2656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.